Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Leucine rich repeat containing 37 member A16, pseudogene (LRRC37A16P) refers to a non-coding, transcribed pseudogene in the human genome, annotated as NCBI Gene ID 651250[1][5]. It does not encode a functional protein product and is not considered a therapeutic target, receptor, or enzyme. Its alias is LRRC37C[1][3]. LRRC37A16P belongs to a family of leucine-rich repeat containing genes but, as a pseudogene, lacks biological functions and disease associations attributable to proteins. Pseudogenes may be transcribed but do not result in functional proteins and generally do not serve as drug targets, biomarkers, or present safety concerns in clinical practice[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Leucine rich repeat containing 37 member A16, pseudogene (LRRC37A16P).